Nonsense-Mediated Decay Targeted RNA (ntRNA): Proposal of a NtRNA-miRNA-lncRNA Triple Regulatory Network Usable As Biomarker of Prognostic Risk in Patients with Kidney Cancer

Overview

Journal Genes (Basel)

Publisher MDPI

Date 2022 Sep 23

PMID 36140823

Authors

Zhiyue Zhou

Fuyan Hu

Dan Huang

Qingjia Chi

Nelson L S Tang

Affiliations

Soon will be listed here.

Abstract

The most prevalent subtype of renal cell carcinoma (RCC), kidney renal clear cell carcinoma (KIRC) may be associated with a poor prognosis in a high number of cases, with a stage-specific prognostic stratification currently in use. No reliable biomarkers have been utilized so far in clinical practice despite the efforts in biomarker research in the last years. Nonsense-mediated mRNA decay (NMD) is a critical safeguard against erroneous transcripts, particularly mRNA transcripts containing premature termination codons (called nonsense-mediated decay targeted RNA, ntRNA). In this study, we first characterized 296 differentially expressed ntRNAs that were independent of the corresponding gene, 261 differentially expressed miRNAs, and 4653 differentially expressed lncRNAs. Then, we constructed a hub ntRNA-miRNA-lncRNA triple regulatory network associated with the prognosis of KIRC. Moreover, the results of immune infiltration analysis indicated that this network may influence the changes of the tumor immune microenvironment. A prognostic model derived from the genes and immune cells associated with the network was developed to distinguish between high- and low-risk patients, which was a better prognostic than other models, constructed using different biomarkers. Additionally, correlation of methylation and ntRNAs in the network suggested that some ntRNAs were regulated by methylation, which is helpful to further study the causes of abnormal expression of ntRNAs. In conclusion, this study highlighted the possible clinical implications of ntRNA functions in KIRC, proposing potential significant biomarkers that could be utilized to define the prognosis and design personalized treatment plans in kidney cancer management in the next future.

References

Kang J, Lee J, Hong D, Lee S, Kim N, Lee W . Renal cell carcinoma escapes death by p53 depletion through transglutaminase 2-chaperoned autophagy. Cell Death Dis. 2016; 7:e2163. PMC: 4823929. DOI: 10.1038/cddis.2016.14. View

Davis A, Grondin C, Johnson R, Sciaky D, Wiegers J, Wiegers T . Comparative Toxicogenomics Database (CTD): update 2021. Nucleic Acids Res. 2020; 49(D1):D1138-D1143. PMC: 7779006. DOI: 10.1093/nar/gkaa891. View

Zhou J, Zhu Y, Liu Y, Niu P, Chen H, Deng J . High PRAS40 mRNA expression and its role in prognosis of clear cell renal cell carcinoma. Transl Androl Urol. 2020; 9(4):1650-1660. PMC: 7475688. DOI: 10.21037/tau-20-741. View

Zhang Y, Liu X, Liu L, Li J, Hu Q, Sun R . Expression and Prognostic Significance of m6A-Related Genes in Lung Adenocarcinoma. Med Sci Monit. 2020; 26:e919644. PMC: 7049251. DOI: 10.12659/MSM.919644. View

Mendell J, Olson E . MicroRNAs in stress signaling and human disease. Cell. 2012; 148(6):1172-87. PMC: 3308137. DOI: 10.1016/j.cell.2012.02.005. View

Lucarelli G, Ferro M, Loizzo D, Bianchi C, Terracciano D, Cantiello F . Integration of Lipidomics and Transcriptomics Reveals Reprogramming of the Lipid Metabolism and Composition in Clear Cell Renal Cell Carcinoma. Metabolites. 2020; 10(12). PMC: 7763669. DOI: 10.3390/metabo10120509. View

Popp M, Maquat L . Organizing principles of mammalian nonsense-mediated mRNA decay. Annu Rev Genet. 2013; 47:139-65. PMC: 4148824. DOI: 10.1146/annurev-genet-111212-133424. View

Wolf J, Auw-Haedrich C, Schlecht A, Boneva S, Mittelviefhaus H, Lapp T . Transcriptional characterization of conjunctival melanoma identifies the cellular tumor microenvironment and prognostic gene signatures. Sci Rep. 2020; 10(1):17022. PMC: 7550331. DOI: 10.1038/s41598-020-72864-0. View

Sakai Y, Honda M, Matsui S, Komori O, Murayama T, Fujiwara T . Development of novel diagnostic system for pancreatic cancer, including early stages, measuring mRNA of whole blood cells. Cancer Sci. 2019; 110(4):1364-1388. PMC: 6447845. DOI: 10.1111/cas.13971. View

10.

Qi-Dong X, Yang X, Lu J, Liu C, Sun J, Li C . Development and Validation of a Nine-Redox-Related Long Noncoding RNA Signature in Renal Clear Cell Carcinoma. Oxid Med Cell Longev. 2021; 2020:6634247. PMC: 7781722. DOI: 10.1155/2020/6634247. View

11.

Isken O, Maquat L . The multiple lives of NMD factors: balancing roles in gene and genome regulation. Nat Rev Genet. 2008; 9(9):699-712. PMC: 3711694. DOI: 10.1038/nrg2402. View

12.

Machnik M, Cylwa R, Kielczewski K, Biecek P, Liloglou T, Mackiewicz A . The expression signature of cancer-associated KRAB-ZNF factors identified in TCGA pan-cancer transcriptomic data. Mol Oncol. 2018; 13(4):701-724. PMC: 6442004. DOI: 10.1002/1878-0261.12407. View

13.

Hazan-Halevy I, Rosenblum D, Weinstein S, Bairey O, Raanani P, Peer D . Cell-specific uptake of mantle cell lymphoma-derived exosomes by malignant and non-malignant B-lymphocytes. Cancer Lett. 2015; 364(1):59-69. PMC: 4490183. DOI: 10.1016/j.canlet.2015.04.026. View

14.

Chin C, Chen S, Wu H, Ho C, Ko M, Lin C . cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014; 8 Suppl 4:S11. PMC: 4290687. DOI: 10.1186/1752-0509-8-S4-S11. View

15.

Garcia-Moreno J, Romao L . Perspective in Alternative Splicing Coupled to Nonsense-Mediated mRNA Decay. Int J Mol Sci. 2020; 21(24). PMC: 7764535. DOI: 10.3390/ijms21249424. View

16.

Zhang S, Zhang E, Long J, Hu Z, Peng J, Liu L . Immune infiltration in renal cell carcinoma. Cancer Sci. 2019; 110(5):1564-1572. PMC: 6501001. DOI: 10.1111/cas.13996. View

17.

He M, Hu F . TF-RBP-AS Triplet Analysis Reveals the Mechanisms of Aberrant Alternative Splicing Events in Kidney Cancer: Implications for Their Possible Clinical Use as Prognostic and Therapeutic Biomarkers. Int J Mol Sci. 2021; 22(16). PMC: 8395830. DOI: 10.3390/ijms22168789. View

18.

Jin L, Zhang Z, Li Y, He T, Hu J, Liu J . miR-125b is associated with renal cell carcinoma cell migration, invasion and apoptosis. Oncol Lett. 2017; 13(6):4512-4520. PMC: 5453059. DOI: 10.3892/ol.2017.5985. View

19.

Hsu M, Lin H, Chen F . NMD Classifier: A reliable and systematic classification tool for nonsense-mediated decay events. PLoS One. 2017; 12(4):e0174798. PMC: 5378362. DOI: 10.1371/journal.pone.0174798. View

20.

Lang F, Linlin M, Ye T, Yuhai Z . Alterations of dendritic cell subsets and TH1/TH2 cytokines in the peripheral circulation of patients with superficial transitional cell carcinoma of the bladder. J Clin Lab Anal. 2012; 26(5):365-71. PMC: 6807352. DOI: 10.1002/jcla.21532. View